NR0B2 and neoplasm: Furthermore, chronic inflammation within the TME promotes tumor progression (34–36), and we observed a decrease in Tregs (CD4+CD25+CD127-), which are known to support tumor growth and suppress anti-tumor immune responses (37, 38) in the PTX+SHP group.